NCT00533598View on ClinicalTrials.gov

A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

September 30, 2002

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions

Obesity

Interventions

DRUG

MK0557

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00533598 - A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED) | Biotech Hunter | Biotech Hunter